Product image of Midiana Continuous (Drospirenone, Ethinylestradiol | Lactose) supplied by GNH India

Midiana Continuous

Active Ingredient:
Drospirenone, Ethinylestradiol | Lactose
Origin:
EU

Midiana Continuous (Drospirenone, Ethinylestradiol | Lactose)

Drospirenone and Ethinylestradiol, the active ingredients in Midiana Continuous, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy and help regulate the menstrual cycle in women of reproductive age.

GNH India supplies Midiana Continuous as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Midiana Continuous, a combined oral contraceptive, is used within the hormonal contraceptive pathway to prevent unintended pregnancy and manage menstrual cycles.

  • Pregnancy prevention: inhibits ovulation and creates conditions unfavorable for fertilization.
  • Menstrual cycle regulation: promotes more predictable bleeding patterns.
  • Hormonal contraception: provides reliable birth control for women seeking estrogen‑progestogen therapy.

How It Works

  • Midiana Continuous combines drospirenone, a synthetic progestogen with anti‑mineralocorticoid activity, and ethinylestradiol, a synthetic estrogen. The estrogen component suppresses follicle‑stimulating hormone, while drospirenone blocks luteinizing hormone release, together inhibiting ovulation. Additionally, drospirenone thickens cervical mucus and alters the endometrial lining, reducing the likelihood of implantation.

Side Effects

Midiana Continuous may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Nausea: mild stomach upset often occurring early in treatment.
  • Headache: tension‑type or migraine‑like headaches.
  • Breast tenderness: temporary swelling or discomfort.
  • Weight gain: modest increase in body weight.
  • Mood changes: irritability or mood swings.
  • Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in deep veins.
  • Pulmonary embolism: clot traveling to lungs.
  • Stroke: cerebrovascular accident.
  • Hepatic adenoma: benign liver tumor.
  • Severe hypertension: markedly elevated blood pressure.
  • Allergic reaction: rash, swelling, or anaphylaxis.

Precautions & Warnings

Before prescribing Midiana Continuous, clinicians should consider several precautionary measures to ensure safe use.

  • Contraindications: avoid in women with a history of thromboembolic disorders.
  • Smoking: do not use in patients over 35 who smoke cigarettes.
  • Cardiovascular risk: assess for hypertension, coronary artery disease, or stroke history.
  • Liver disease: use cautiously in patients with active liver disease.
  • Pregnancy and lactation: discontinue if pregnancy is confirmed; not recommended during breastfeeding.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and light.

Avoid Interactions

Midiana Continuous can interact with several medicines, altering its effectiveness or increasing adverse risk.

Major Interactions (Avoid)

  • Anticoagulants: may reduce efficacy of warfarin, requiring monitoring.
  • Antiepileptics: enzyme inducers like carbamazepine can lower hormone levels.
  • Antiretrovirals: protease inhibitors may increase hormone concentrations.
  • Rifampicin: strong inducer decreasing contraceptive effectiveness.
  • St. John’s wort: herbal inducer that can diminish contraceptive efficacy.

Moderate Interactions (Monitor Closely)

  • Antibiotics: some may slightly reduce hormone levels (e.g., tetracycline).
  • Diuretics: may increase risk of potassium loss with drospirenone.
  • Antifungals: azoles can increase hormone levels, requiring observation.
  • Thyroid hormones: may affect binding proteins, necessitating dose review.

Frequently Asked Questions

Midiana Continuous is a combined oral contraceptive indicated for the prevention of unintended pregnancy and for regulation of the menstrual cycle in women of reproductive age. It provides reliable hormonal birth control and can help achieve more predictable bleeding patterns.

Drospirenone is a synthetic progestogen that blocks luteinizing hormone release, while ethinylestradiol is a synthetic estrogen that suppresses follicle‑stimulating hormone. Together they inhibit ovulation, thicken cervical mucus, and modify the endometrial lining, creating an environment that prevents fertilization and implantation.

The dosing regimen for Midiana Continuous is determined by the prescribing clinician. Typically, the product is taken as one tablet daily at the same time each day, but the exact schedule and duration are individualized based on the patient’s medical history and treatment goals.

Midiana Continuous is contraindicated once pregnancy is confirmed and is not recommended for use while breastfeeding. Women should discontinue the product if they become pregnant and discuss alternative contraception or postpartum options with their healthcare provider.

To order Midiana Continuous, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Midiana Continuous contains drospirenone, which has anti‑mineralocorticoid properties that may reduce water retention compared with some other progestogens. Its efficacy in preventing pregnancy is comparable to other estrogen‑progestogen pills, but individual tolerability and side‑effect profiles can differ, making clinician selection important.

Midiana Continuous tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct light, and keep out of reach of children.

Midiana Continuous is administered orally. The tablet is swallowed whole with water, usually at the same time each day, without regard to meals. Consistent daily intake helps maintain steady hormone levels and maximizes contraceptive effectiveness.

Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, and stroke, especially in women with pre‑existing risk factors. Other rare but severe reactions can involve severe hypertension, hepatic adenoma, and allergic anaphylaxis. Prompt medical attention is required if any of these occur.

Women with a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known hypersensitivity to drospirenone or ethinylestradiol, or who are pregnant or breastfeeding should not use Midiana Continuous. Smoking women over 35 years of age are also advised against its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Drospirenone, Ethinylestradiol | Lactose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT